DK1094069T3 - DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf - Google Patents

DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf

Info

Publication number
DK1094069T3
DK1094069T3 DK00203555T DK00203555T DK1094069T3 DK 1094069 T3 DK1094069 T3 DK 1094069T3 DK 00203555 T DK00203555 T DK 00203555T DK 00203555 T DK00203555 T DK 00203555T DK 1094069 T3 DK1094069 T3 DK 1094069T3
Authority
DK
Denmark
Prior art keywords
structural protein
applications
dna encoding
infectious salmon
anemia virus
Prior art date
Application number
DK00203555T
Other languages
English (en)
Other versions
DK1094069T4 (da
Inventor
Erik Biering
Bjorn Krossoy
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1094069(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1094069T3 publication Critical patent/DK1094069T3/da
Publication of DK1094069T4 publication Critical patent/DK1094069T4/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10RNA viruses
    • C07K16/108Orthomyxoviridae (F), e.g. influenza virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00203555T 1999-10-18 2000-10-12 DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf DK1094069T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203401 1999-10-18

Publications (2)

Publication Number Publication Date
DK1094069T3 true DK1094069T3 (da) 2005-05-17
DK1094069T4 DK1094069T4 (da) 2008-07-21

Family

ID=8240749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00203555T DK1094069T4 (da) 1999-10-18 2000-10-12 DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf

Country Status (10)

Country Link
US (1) US6471964B1 (da)
EP (1) EP1094069B2 (da)
JP (1) JP4777508B2 (da)
AT (1) ATE286507T1 (da)
AU (1) AU778791B2 (da)
CA (1) CA2321437A1 (da)
DE (1) DE60017229D1 (da)
DK (1) DK1094069T4 (da)
NO (1) NO330866B1 (da)
NZ (1) NZ507530A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6304100A (en) * 1999-08-07 2001-03-05 Novartis Ag Sequence
WO2001066569A1 (en) * 2000-03-08 2001-09-13 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
CA2393895A1 (en) * 2001-07-17 2003-01-17 University Of Prince Edward Island Serological test for isav in fish
ATE505482T1 (de) * 2001-10-19 2011-04-15 Intervet Int Bv Impfstoff gegen infektiöses lachsanämievirus
TWI350310B (en) 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
NZ578541A (en) 2006-12-22 2012-04-27 Soluciones Biotecnologicas Innovacion Ltda Dna vaccines for fish
EP2482824B1 (en) 2009-10-02 2016-11-30 The Trustees of Columbia University in the City of New York Piscine reovirus immunogenic compositions
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990063914A (ko) * 1995-10-18 1999-07-26 빌프리더 하이더 이미노아세트산 아미드 및 해충 구제제로서의 그의용도
ATE331030T1 (de) * 1996-11-04 2006-07-15 Ottawa Health Research Inst Verfahren zur expression von polypeptide in fishen durch wässerung in dns enthaltende lösung
KR20010032336A (ko) * 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
AU6304100A (en) * 1999-08-07 2001-03-05 Novartis Ag Sequence

Also Published As

Publication number Publication date
NO330866B1 (no) 2011-08-01
EP1094069B2 (en) 2008-04-23
US6471964B1 (en) 2002-10-29
NO20005217L (no) 2001-04-19
JP2001211888A (ja) 2001-08-07
DK1094069T4 (da) 2008-07-21
EP1094069A1 (en) 2001-04-25
CA2321437A1 (en) 2001-04-18
AU778791B2 (en) 2004-12-23
JP4777508B2 (ja) 2011-09-21
EP1094069B1 (en) 2005-01-05
ATE286507T1 (de) 2005-01-15
NO20005217D0 (no) 2000-10-17
AU6653800A (en) 2001-04-26
DE60017229D1 (de) 2005-02-10
NZ507530A (en) 2001-08-31

Similar Documents

Publication Publication Date Title
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
DK1328543T3 (da) Nukleinsyrer og proteiner fra streptococcus-gruppe A & B
ATE329616T1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
PT702085E (pt) Virus de arn de cadeia negativa nao segmentada infeccioso recombinante
PT1219711E (pt) Vacina de lawsonia intracellularis
DK1094069T3 (da) DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
DE60034884D1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
NO175153C (no) Polypeptider
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
NO20041564L (no) Infeksios lakse anemi-virus vaksine
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
Zrein et al. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus